Healthcare - Biotechnology - NASDAQ - US
$ 1.83
0.274 %
$ 89.8 M
Market Cap
-11.44
P/E
CASH FLOW STATEMENT
-7.43 M
OPERATING CASH FLOW
39.9 M
INVESTING CASH FLOW
0
FINANCING CASH FLOW
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis
MediciNova, Inc.
| Net Income | -8.57 M |
| Depreciation & Amortization | 20.3 K |
| Capital Expenditures | -21.3 K |
| Stock-Based Compensation | 711 K |
| Change in Working Capital | 112 K |
| Others | 390 K |
| Free Cash Flow | -7.45 M |
Cash Flow
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | Dec-2017 | Dec-2016 | Dec-2015 | Dec-2014 | Dec-2013 | Dec-2012 | Dec-2011 | Dec-2010 | Dec-2009 | Dec-2008 | Dec-2007 | Dec-2006 | Dec-2005 | Dec-2004 | Dec-2003 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| OPERATING CASH FLOW | |||||||||||||||||||||
| Net Income | (8.6) | (14.1) | (10.1) | (13.9) | (12.9) | (14.7) | (11.2) | (10.9) | (8.8) | (9.2) | (4.0) | (11.0) | (17.7) | (20.2) | (20.4) | (21.9) | (48.9) | (35.7) | (25.7) | (48.3) | (6.2) |
| Depreciation & Amortization | 20.3 K | 17.7 K | 26.1 K | 21.3 K | 23.9 K | 25.9 K | 28.1 K | 14.1 K | 26.7 K | 40.2 K | 0.1 | 69.5 K | 41.9 K | 0.1 | 0.2 | 0.3 | 0.3 | (0.3) | (0.7) | 45.3 K | 29.9 K |
| Deferred Income Tax | 0 | 0 | 286 | (3.4) | (4.0) | 0 | (1.9) | 1.9 K | 0 | 9.56 K | 18.1 K | 823 | 0 | 0 | (1 956.0) | 0 | 0 | (2 090.2) | (439.2) | (34 294.5) | 0 |
| Stock Based Compensation | 0.7 | 0.6 | 1.7 | 3.2 | 4.1 | 6.3 | 4.5 | 4.0 | 2.0 | 1.6 | 1.2 | 0.7 | 1.4 | 2.0 | 2.4 | 3.2 | 0 | 2 090.2 | 439.2 | 34 294.5 | 0 |
| Other Operating Activities | 0.3 | 0.2 | 0.2 | 3.4 | 4.0 | 19.9 K | 1.9 | 32.1 K | 34.3 K | 3.81 K | 3.26 K | (0.8) | 0.8 | 1.4 | 1 955.7 | 0.6 | 3.9 | 2.1 | 0.4 | 34.3 | 0 |
| Change in Working Capital | 0.1 | 0.3 | (1.2) | (0.2) | (0.3) | (0.8) | (0.3) | 0.3 | (0.4) | 8.3 | (7.9) | (0.9) | 2.3 | (1.0) | 1.1 | (3.2) | 0.8 | (0.2) | 3.1 | 0.4 | 0.2 |
| Cash From Operations | (7.4) | (12.9) | (9.4) | (10.8) | (9.1) | (9.1) | (6.9) | (6.5) | (7.2) | 0.8 | (10.6) | (11.9) | (13.3) | (17.7) | (17.0) | (21.1) | (43.9) | (34.1) | (22.9) | (13.5) | (5.9) |
| INVESTING CASH FLOW | |||||||||||||||||||||
| Capital Expenditures | 21.3 K | 5.01 K | 28.7 K | 36.5 K | 11.3 K | 10.2 K | 0 | 84.5 K | 2.32 K | 3.52 K | 41.6 K | 83.4 K | 6.08 K | 18.6 K | 16.4 K | 0 | (0.4) | (0.2) | (1.0) | (0.3) | 10.5 K |
| Other Items | 39.9 | (40.0) | 0 | 0 | 0 | 0.6 | (84.5) | 0 | 0 | 0 | 4.8 K | (0.7) | 0 | 27.7 | (1.1) | 21.6 | 44.0 | 6.0 | (88.2) | (10.8) | (1.1) |
| Cash From Investing Activities | 39.9 | (40.0) | 28.7 K | 36.5 K | 11.3 K | 0.6 | (84.5) | 84.5 K | 2.32 K | 3.52 K | 36.8 K | (0.8) | 6.08 K | 27.6 | (1.1) | 21.6 | 43.6 | 5.8 | (89.1) | (11.1) | (1.1) |
| FINANCING CASH FLOW | |||||||||||||||||||||
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 8.23 K | 37.5 K | 0 | 0 | 0 | (1.4) | 55.4 K | (1.1) | 0 |
| Total Debt Repaid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | (14.9) | (1.1) | 17.6 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 0 | 0 | (0.1) | (0.2) | (0.3) | 51 K | 77.3 K | 87.7 K | 89.9 K | 60.5 K | 6.7 K | 58.6 K | 5.4 | 0 | 0 | 0 | 0 | 0 | 0 | (0.3) | 10.0 |
| Cash From Financing Activities | 0 | 7.92 K | 20.8 | 7.1 | 10.6 | 42.8 | 10.8 | 8.7 | 17.6 | 4.2 | 13.4 | 1.5 | 0.2 | (0.9) | 18.1 | 86.7 K | 10.7 | (1.1) | 110.9 | 59.2 | 10.0 |
| CHANGE IN CASH | |||||||||||||||||||||
| Net Change In Cash | 32.5 | (52.9) | 11.4 | (3.8) | 1.5 | 34.3 | 3.9 | 2.0 | 10.4 | 5.0 | 2.7 | (11.1) | (13.2) | 9.0 | 55.7 K | 0.5 | 10.4 | (29.3) | (1.1) | 34.6 | 3.0 |
| FREE CASH FLOW | |||||||||||||||||||||
| Free Cash Flow | (7.5) | (12.9) | (9.4) | (10.9) | (9.1) | (9.1) | (6.9) | (6.6) | (7.2) | 0.8 | (10.7) | (11.9) | (13.3) | (17.7) | (17.0) | (21.1) | (44.2) | (34.3) | (23.9) | (13.9) | (5.9) |